Kiernan Seth is VP, Chief Commercial Officer of LEXICON PHARMACEUTICALS, INC.. Currently has a direct ownership of 53,136 shares of LXRX, which is worth approximately $37,726. The most recent transaction as insider was on Feb 28, 2023, when has been sold 11,813 shares (Common Stock) at a price of $2.17 per share, resulting in proceeds of $25,634. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 53.1K
0% 3M change
0% 12M change
Total Value Held $37,726

Kiernan Seth Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 28 2023
SELL
Payment of exercise price or tax liability
$25,634 $2.17 p/Share
11,813 Reduced 18.19%
53,136 Common Stock
Feb 28 2023
BUY
Exercise of conversion of derivative security
-
43,082 Added 39.88%
64,949 Common Stock
Feb 28 2022
SELL
Payment of exercise price or tax liability
$23,544 $2.85 p/Share
8,261 Reduced 27.42%
21,867 Common Stock
Feb 28 2022
BUY
Exercise of conversion of derivative security
-
30,128 Added 50.0%
30,128 Common Stock
KS

Kiernan Seth

VP, Chief Commercial Officer
The Woodlands, TX

Track Institutional and Insider Activities on LXRX

Follow LEXICON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LXRX shares.

Notify only if

Insider Trading

Get notified when an Lexicon Pharmaceuticals, Inc. insider buys or sells LXRX shares.

Notify only if

News

Receive news related to LEXICON PHARMACEUTICALS, INC.

Track Activities on LXRX